Disclosure Content. Pfizer may identify Institution and Principal Investigator, and will differentiate clearly between payments or other transfers of value made to institutions and those made to individuals. Disclosures may include identifying information for institutions and investigators, such as name, business address, specialty, license numbers.
Appears in 2 contracts
Samples: General Research Grant Agreement, General Research Grant Agreement
Disclosure Content. Pfizer may identify Institution and Principal Coordinating Investigator, and will differentiate clearly between payments or other transfers of value made to institutions and those made to individuals. Disclosures may include identifying information for institutions and investigators, such as name, business address, specialty, or license numbers.
Appears in 1 contract
Disclosure Content. In a transparency disclosure, Pfizer may identify both the Institution and the Principal Investigator, and but will clearly differentiate clearly between payments or other transfers of value made to institutions and those made to individuals. Disclosures may include identifying information for institutions and investigators, such as name, business address, specialty, license National Provider Identifier (“NPI”), and licensure numbers.
Appears in 1 contract
Samples: Research Agreement